Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 82804-080

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 82804-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-080-90 (150mg 90ct)

82804-080-90 (150mg 90ct)
This is a description of Bupropion HCI 150mg extended-release tablets, each tablet containing Bupropion hydrochloride, manufactured in Yichang, Hubei, China, and packaged by Proficient Rx LP in Thousand Oaks, CA. The tablets are white to pale yellow, round biconvex with the imprint "YH 102." It is advised not to use this medication in combination with ZYBAN or any other medicines containing bupropion hydrochloride. The medication guide should be provided to each patient separately. The tablets should be stored between 20°-25°C (68°-77°F), and kept out of the reach of children. Each package contains 90 XL tablets.*
FDA Label Image

Bupropion-structure (Bupropion Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.